It progresses silently, often detected only when significant damage has already occurred
Similarly, a recent study demonstrated that inhibiting the JAK2-STAT3 pathway with stattic to block STAT3 effectively alleviated inflammation and fibrosis in LPS-induced CKD [251]
Fatigue is a recognised side effect when starting glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or liraglutide (Victoza, Saxenda)
In the same trial, 44% of participants on 9 mg mazdutide reached at least 20% weight loss, versus 2.6% on placebo
If you found it useful, the only thing I ask you in return is to share it with a friend
Find out in our article about supplements to take or avoid with GLP-1s